A cancerous transition mechanism in lung fibroblasts relies upon the deregulated expression of Rb2/p130, which is controlled by CTCF, and has been shown to promote the progression and recurrence of lung cancer after treatment. This evidence concerns the gene RBL2 and lung carcinoma.